Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2006
12/27/2006EP1734985A2 Methods for suppressing neovascularization using ephrinb2
12/27/2006EP1734926A2 Aqueous solutions comprising prednisolone and a cyclodextrin derivative
12/27/2006EP1534282B1 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
12/27/2006EP1443925B1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
12/27/2006EP1440159B1 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
12/27/2006EP1406876B1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/27/2006EP1368317B1 Tryptase inhibitors
12/27/2006EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
12/27/2006EP1299374B1 Novel non-psychotropic cannabinoids
12/27/2006EP1284717B1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
12/27/2006EP1173255B1 Use of pirenoxine for the protection of corneal tissues in photokeratectomy
12/27/2006EP1021410B1 Prostaglandin agonists and their use to treat bone disorders
12/27/2006EP0973804B1 Anti-vegf antibodies
12/27/2006EP0844875B1 Use of basic l-carnitine and acyl derivatives for lowering ceramide levels
12/27/2006CN1886423A Glycoisoforms of adiponectin and uses thereof
12/27/2006CN1886375A Piperidine compound and method for producing same
12/27/2006CN1886138A CDK2 antagonists as short form C-MAF transcription factor antagonists for treatment of glaucoma
12/27/2006CN1883671A Liver-benefiting blood circulation-activating eyesight-improving granule
12/27/2006CN1883670A Liver-benefiting blood circulation-activating eyesight-improving tablet
12/27/2006CN1883669A Liver-benefiting blood circulation-activating eyesight-improving capsule
12/27/2006CN1883601A Chinese medicinal capsule for treating inflammation and method for preparing same
12/27/2006CN1883560A A compound Chinese medicinal preparation containing Chinese globeflower and method for preparing same
12/27/2006CN1883539A A Chinese medicinal composition and method for preparing same
12/27/2006CN1883524A Eyesight-improving capsule and preparation process thereof
12/27/2006CN1883491A Medical use of ginsenoside Rh 1
12/27/2006CN1883469A An ocular microemulsion containing Vitamin A and Vitamin E and preparation method thereof
12/27/2006CN1883464A Ophthalmic preparation containing sodium new houttuyfonate
12/27/2006CN1291988C Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient
12/26/2006US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives
12/26/2006US7153873 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety
12/26/2006US7153867 Use of nitrogen substituted thalidomide analogs for the treatment of macular degenerator
12/26/2006US7153862 αv integrin receptor antagonists
12/26/2006US7153859 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease
12/26/2006US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer
12/26/2006US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders
12/26/2006US7153850 Lactam compounds and pharmaceutical use thereof
12/26/2006US7153837 Agent for protection of retinal neurons
12/26/2006US7153833 Therapeutic uses of SMR1 peptides
12/26/2006US7153501 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
12/21/2006WO2006134146A1 Orthopaedic skeletal demonstration aids
12/21/2006WO2006058303A3 Modulators of muscarinic receptors
12/21/2006WO2006037106A3 Carboxy-amido-triazoles for the localized treatment of ocular diseases
12/21/2006US20060287389 Phenethanolamine derivatives for treatment of respiratory diseases
12/21/2006US20060287374 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/21/2006US20060287338 Metalloproteinase inhibitor compounds
12/21/2006US20060287336 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
12/21/2006US20060287286 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent
12/21/2006US20060287246 Remedy for eye diseases accompanied by optic nerve injuries
12/21/2006US20060287225 injecting an alpha-v. beta 3 or alpha-v, beta 5 inhibitor into the vitreous body of the eye; angiogenesis inhibition; diabetic retinopathy, macular degeneration, myopia, ocular histoplasmosis; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid
12/21/2006US20060286173 Drug delivery system for sub-tenon s capsule adminstration of fine grains
12/21/2006US20060286150 Prevent menopause syndrome; therapy for skin aging; topical applying
12/20/2006EP1734040A1 Substituted quinazoline or pyridopyrimidine derivative
12/20/2006EP1733740A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
12/20/2006EP1733728A2 Use of 2-alkoxyphenyl substituted imidazotriazinones as inhibitors of phosphodiesterase
12/20/2006EP1733727A1 Ferrocenecarboxamide derivatives for use as dopamine D3 ligands for the treatment of CNS disorders
12/20/2006EP1732574A1 The use of o-atp for the treatment of diseases involving angiogenesis
12/20/2006EP1732567A1 Use of a phenothiazine derivative for preventing and/or treating hearing loss
12/20/2006EP1732543A2 Tetra-cyclic carboline deratives for inhibiting angiogenesis
12/20/2006EP1401809B1 Tryptase inhibitors
12/20/2006EP1187816B1 5-cyano-2-aminopyrimidine derivatives
12/20/2006EP1135477B1 Humanized monoclonal integrin antibodies
12/20/2006CN1882375A Treatment of amyloid- and epileptogenesis-associated diseases
12/20/2006CN1880306A Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/20/2006CN1880301A Tiopronin lysine and its preparing process and use
12/20/2006CN1879836A A medicine for treating children's excessive blink, hyperkinetic syndrome and Tottre's syndrome and method for preparing same
12/20/2006CN1879807A Natural herbal eye-care cream
12/20/2006CN1879782A Chinese medicinal preparation for increasing memory and improving eyesight and method for preparing same
12/20/2006CN1879719A Medicine for treating Menieres syndrom
12/20/2006CN1879651A Eye drop containing micro-elements and preparation method thereof
12/20/2006CN1879639A A nanometer 'Xue Shuan Tong' injection and preparation method thereof
12/20/2006CN1879625A In situ-forming eye gel composition of ganciclovir and preparation method thereof
12/20/2006CN1879619A Cancer treatment
12/20/2006CN1879605A A micro-emulsion type artificial tear
12/20/2006CN1879602A An ocular gel preparation and preparation method thereof
12/20/2006CN1290848C Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/20/2006CN1290842C Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
12/20/2006CN1290577C Application of interleukin-1 in medicine preparation process for treating glaucoma
12/20/2006CN1290576C Use of thymic hormone beta 15 in preparation of substances for promoting wound healing and generation of blood
12/20/2006CN1290503C Oral liquid of compound anisodine, preparation method and usage
12/19/2006US7151169 For therapy of fibrosis, immune responses and tumor progression, asthma
12/19/2006US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006US7151117 Administering a X-ray contrast media selected from iotrolan and iodixannol to an eye of a mammal suffering from allergic conjunctivitis and allergic rhinitis to decrease in histamine release; side effect reduction
12/19/2006US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases
12/19/2006US7151098 Glutamate receptor antagonists
12/19/2006CA2301685C Sustained release drug delivery devices
12/19/2006CA2264979C Dicyclic-aromatic compounds and their application in human and veterinary medicine, as well as in cosmetics
12/19/2006CA2251623C Buccal delivery system
12/19/2006CA2232880C Semi-fluorinated alkanes and their use
12/19/2006CA2155200C Use of topical anesthetics for the treatment of eosinophil-associated diseases
12/19/2006CA2149496C 11,21-bisphenyl-19-norpregnane derivatives
12/14/2006WO2006132442A1 Vitamin d-like compound
12/14/2006WO2006132342A1 Eye drop containing roflumilast
12/14/2006WO2006132205A1 Radical scavenger and active oxygen eliminating agent
12/14/2006WO2006131054A1 Chinese pharmaceutical ophthalmological formulations in forms of solutions, ointments and pills for antiaging recovery
12/14/2006WO2006130949A1 Anti amyloid-related disease molecules and their uses
12/14/2006WO2006111776A3 Pharmaceutical composition comprising serum obtained from a naive mammal
12/14/2006WO2001022972A9 Immunostimulatory nucleic acids
12/14/2006US20060281887 (Meth)acrylate copolymer for use as medical carrier
12/14/2006US20060281820 Lfa-1 inhibitors and use thereof
12/14/2006US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof